Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
The Journal of Organic Chemistry
|
June 26, 1996
Stereodynamics of 9,11-Diphenyl-10-azatetracyclo[6.3.0.0.(4,11)0.(5,9)]undecanes. Highly Restricted Nitrogen Inversion and Isolated Phenyl Rotation. X-ray Crystallographic, Dynamic NMR, and Molecular Mechanics Studies
Gordon W. Gribble, Frank L. Switzer, John H. Bushweller, et al.
The Journal of Biological Chemistry
|
August 25, 2005
2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancer
Ismael Samudio, Marina Konopleva, Numsen Hail, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2008
Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268
Karen Liby, Renee Risingsong, Darlene B Royce, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo
Andrew E Place, Nanjoo Suh, Charlotte R Williams, et al.
Molecular Cancer Therapeutics
|
July 11, 2007
Novel semisynthetic analogues of betulinic acid with diverse cytoprotective, antiproliferative, and proapoptotic activities
Karen Liby, Tadashi Honda, Charlotte R Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2005
Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress
Albena T Dinkova-Kostova, Karen T Liby, Katherine K Stephenson, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 21, 2019
First-generation structure-activity relationship studies of 2,3,4,9-tetrahydro-1H-carbazol-1-amines as CpxA phosphatase inhibitors
Yangxiong Li, Jessi J Gardner, Katherine R Fortney, et al.
Molecular Cancer Therapeutics
|
May 17, 2008
The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis
Karen Liby, Candice C Black, Darlene B Royce, et al.
Cancer Research
|
March 22, 2003
Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling
Nanjoo Suh, Anita B Roberts, Stephanie Birkey Reffey, et al.
Cancer Research
|
June 3, 2005
The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling
Karen Liby, Thomas Hock, Mark M Yore, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
The Journal of Organic Chemistry
|
June 26, 1996
Stereodynamics of 9,11-Diphenyl-10-azatetracyclo[6.3.0.0.(4,11)0.(5,9)]undecanes. Highly Restricted Nitrogen Inversion and Isolated Phenyl Rotation. X-ray Crystallographic, Dynamic NMR, and Molecular Mechanics Studies
Gordon W. Gribble, Frank L. Switzer, John H. Bushweller, et al.
The Journal of Biological Chemistry
|
August 25, 2005
2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancer
Ismael Samudio, Marina Konopleva, Numsen Hail, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2008
Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268
Karen Liby, Renee Risingsong, Darlene B Royce, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo
Andrew E Place, Nanjoo Suh, Charlotte R Williams, et al.
Molecular Cancer Therapeutics
|
July 11, 2007
Novel semisynthetic analogues of betulinic acid with diverse cytoprotective, antiproliferative, and proapoptotic activities
Karen Liby, Tadashi Honda, Charlotte R Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2005
Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress
Albena T Dinkova-Kostova, Karen T Liby, Katherine K Stephenson, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 21, 2019
First-generation structure-activity relationship studies of 2,3,4,9-tetrahydro-1H-carbazol-1-amines as CpxA phosphatase inhibitors
Yangxiong Li, Jessi J Gardner, Katherine R Fortney, et al.
Molecular Cancer Therapeutics
|
May 17, 2008
The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis
Karen Liby, Candice C Black, Darlene B Royce, et al.
Cancer Research
|
March 22, 2003
Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling
Nanjoo Suh, Anita B Roberts, Stephanie Birkey Reffey, et al.
Cancer Research
|
June 3, 2005
The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling
Karen Liby, Thomas Hock, Mark M Yore, et al.
Page
of 8